EdgarLookup

ADIAL PHARMACEUTICALS, INC. — 8-K Filings

141 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ADIAL PHARMACEUTICALS, INC. (ADIL), sorted by most recent first. Each row links to the full filing on EdgarLookup. ADIAL PHARMACEUTICALS, INC. has filed 141 8-K documents with the SEC since 2011. To view all SEC filings by ADIAL PHARMACEUTICALS, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 25-NSE 3 4 4/A 424B3 424B4 424B5 8-A12B 8-A12B/A 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP NT 10-Q NT 10-Q/A POS AM PRE 14A PRER14A RW S-1 S-1/A S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-23-055881 Jul 10, 2023 Jul 7, 2023
8-K CURRENT REPORT 0001213900-23-047706 Jun 9, 2023
8-K CURRENT REPORT 0001213900-23-045360 Jun 2, 2023 May 31, 2023
8-K CURRENT REPORT 0001213900-23-042737 May 24, 2023 May 19, 2023
8-K CURRENT REPORT 0001213900-23-039032 May 12, 2023
8-K CURRENT REPORT 0001213900-23-038128 May 10, 2023 May 8, 2023
8-K CURRENT REPORT 0001213900-23-029521 Apr 13, 2023 Apr 12, 2023
8-K CURRENT REPORT 0001213900-23-024937 Mar 31, 2023 Mar 30, 2023
8-K CURRENT REPORT 0001213900-23-021587 Mar 21, 2023 Mar 15, 2023
8-K CURRENT REPORT 0001213900-23-018221 Mar 7, 2023 Mar 6, 2023
8-K CURRENT REPORT 0001213900-23-016445 Mar 2, 2023 Feb 28, 2023
8-K CURRENT REPORT 0001213900-23-014583 Feb 27, 2023 Feb 24, 2023
8-K CURRENT REPORT 0001213900-23-014138 Feb 24, 2023 Feb 23, 2023
8-K CURRENT REPORT 0001213900-23-013087 Feb 21, 2023
8-K CURRENT REPORT 0001213900-23-006693 Feb 1, 2023 Jan 27, 2023
8-K CURRENT REPORT 0001213900-22-072556 Nov 15, 2022 Nov 14, 2022
8-K CURRENT REPORT 0001213900-22-063864 Oct 13, 2022
8-K CURRENT REPORT 0001213900-22-058942 Sep 26, 2022
8-K CURRENT REPORT 0001213900-22-055945 Sep 14, 2022 Sep 13, 2022
8-K CURRENT REPORT 0001213900-22-055409 Sep 13, 2022 Sep 8, 2022
8-K CURRENT REPORT 0001213900-22-054070 Sep 6, 2022
8-K CURRENT REPORT 0001213900-22-053951 Sep 2, 2022 Aug 31, 2022
8-K CURRENT REPORT 0001213900-22-050245 Aug 23, 2022 Aug 18, 2022
8-K CURRENT REPORT 0001213900-22-048487 Aug 16, 2022
8-K CURRENT REPORT 0001213900-22-040399 Jul 20, 2022
8-K CURRENT REPORT 0001213900-22-035069 Jun 27, 2022
8-K CURRENT REPORT 0001213900-22-026743 May 16, 2022
8-K CURRENT REPORT 0001213900-22-009734 Feb 28, 2022 Feb 22, 2022
8-K CURRENT REPORT 0001213900-22-007632 Feb 14, 2022 Feb 10, 2022
8-K CURRENT REPORT 0001213900-22-006051 Feb 9, 2022
8-K CURRENT REPORT 0001213900-21-066864 Dec 22, 2021 Dec 17, 2021
8-K CURRENT REPORT 0001213900-21-064319 Dec 9, 2021 Dec 6, 2021
8-K CURRENT REPORT 0001213900-21-062467 Nov 30, 2021 Nov 29, 2021
8-K CURRENT REPORT 0001213900-21-058444 Nov 12, 2021 Nov 9, 2021
8-K CURRENT REPORT 0001213900-21-056469 Nov 3, 2021 Nov 2, 2021
8-K CURRENT REPORT 0001213900-21-054113 Oct 22, 2021 Oct 21, 2021
8-K CURRENT REPORT 0001213900-21-051650 Oct 6, 2021 Oct 5, 2021
8-K CURRENT REPORT 0001213900-21-050629 Sep 29, 2021 Sep 27, 2021
8-K CURRENT REPORT 0001213900-21-045799 Aug 31, 2021
8-K CURRENT REPORT 0001213900-21-040445 Aug 5, 2021 Aug 4, 2021
8-K CURRENT REPORT 0001213900-21-037166 Jul 16, 2021 Jul 13, 2021
8-K CURRENT REPORT 0001213900-21-036263 Jul 9, 2021 Jul 6, 2021
8-K CURRENT REPORT 0001213900-21-035692 Jul 6, 2021
8-K CURRENT REPORT 0001213900-21-034036 Jun 25, 2021 Jun 24, 2021
8-K CURRENT REPORT 0001213900-21-033650 Jun 23, 2021 Jun 22, 2021
8-K CURRENT REPORT 0001213900-21-030853 Jun 4, 2021 Jun 1, 2021
8-K CURRENT REPORT 0001213900-21-020935 Apr 9, 2021 Apr 5, 2021
8-K CURRENT REPORT 0001213900-21-015275 Mar 15, 2021 Mar 11, 2021
8-K CURRENT REPORT 0001213900-21-011956 Feb 26, 2021 Feb 25, 2021
8-K FORM 8-K 0001213900-21-009037 Feb 12, 2021 Feb 8, 2021